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Abstract: Polyetheretherketone (PEEK) is a high-performance thermoplastic biomaterial which is currently used in a 
variety of biomedical orthopaedic applications. It has comparable tensile and compressive strength to cortical bone with 
favourable biocompatibility. However, natural grade PEEK-OPTIMA has shown insufficient bioactivity and limited 
bone integration. Bioactive PEEK composites (e.g., PEEK/calcium phosphates or Bioglass) and porous PEEK have been 
used to improve bone-implant interface of PEEK-based devices, but the bioactive phase distribution or porosity control 
is poor. In this paper, a novel method is developed to fabricate a bioactive PEEK/hydroxyapatite (PEEK/HA) composite 
with a unique configuration in which the HA (bioactive phase) distribution is computer-controlled within a PEEK 
matrix. This novel process results in complete interconnectivity of the HA network within a composite material, 
representing a superior advantage over alternative forms of product. The technique combines extrusion freeforming, a 
type of additive manufacturing (AM), and compression moulding. Compression moulding parameters, including pres-
sure, temperature, dwelling time, and loading method together with HA microstructure were optimized by 
experimentation for successful biocomposite production. PEEK/HA composites with a range of HA were produced us-
ing static pressure loading to minimise air entrapment within PEEK matrix. In addition, the technique can also be em-
ployed to produce porous PEEK structures with controlled pore size and distribution. 
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1. Introduction 
olyetheretherketone (PEEK) is a semi-crystal-
line thermoplastic with excellent fibroblasts and 
osteoblasts biocompatibility, and with desirable 
mechanical properties such as strength, stiffness, 
and great thermal stability. Elastic modulus of PEEK 
is similar to that of cortical bone, which can reduce 
stress shielding following implantation. It is also radi-
olucent which permits radiographic assessment. The 
combination of these optimal properties has made 
PEEK of great potential for orthopaedic application. 
Medical grade PEEK-OPTIMA has been developed to 
meet the US Food and Drug Administration’s (FDA) 
requirements and has been used in multiple clinical 
applications including spinal cage fusion and crani-
omaxillofacial reconstruction. Despite possessing fa-
vourable biomaterial properties as described above, 
PEEK is relatively bioinert, demonstrating poor 
osteointegration following implantation. Lack of bio-
integration can result in graft migration, and failure of 
the reconstructive procedure. Three main approaches 
are being developed to enhance bone apposition of 
PEEK-based implants for orthopaedic application: 
• Incorporating bioactive materials  such as cal-
cium phosphates into PEEK to improve the 
bone-implant apposition, 
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• Coating PEEK implants with biomaterials such 
as titanium and/or calcium phosphates, 
• Incorporating porosity into PEEK implants to 
enhance osteointegration and bone fixation. 
Calcium phosphates including hydroxyapatite (HA) 
and β-tricalcium phosphate (β-TCP), or Bioglass can 
be utilised as composite filler to produce PEEK com-
pounds with potential for osteointegration. Whilst ad-
dition of bioactive materials to PEEK offers an effi-
cient method to engineer implants with tailored bio-
mechanical properties, it may result in reduced 
strength and toughness of the implant[1]. Different 
processing methods such as compounding and 
injection moulding[2–4], compression moulding[5–8], 
cold press sintering[9–11] and selective laser sintering 
(SLS)[12–14] have been used to produce bioactive 
PEEK/HA and β-TCP composites.  
Compounding and injection moulding is a low-cost 
process suitable for high-volume commercial near net 
shape manufacturing of PEEK compounds. However, 
the quantity at which bioactive fillers may be loaded is 
strictly limited, as high loading increases melt viscos-
ity resulting in inconsistent and unreliable mixing[1]. 
Furthermore, material removal may be required to 
reveal bioactive particles on the surface of injection 
moulded PEEK compound. In cold press sintering, 
there is no limitation on the loading of bioactive fillers 
but the process suffers from residual porosity in 
composite due to pressure reduction during sintering. 
In contrast, compression moulding is a manufacturing 
platform offering greater flexibility, and shown to be 
well-suited to the synthesis of PEEK/HA composites. 
Compression moulding is low-cost, suitable for 
high-volume production of high-density PEEK com-
pounds, and more critically tailored porosity. In this 
technique, porous PEEK compounds can be realized 
by the addition of a fugitive particle (e.g., sodium 
chloride) into the compound that is further leached out 
by soaking into a solvent post-moulding[1]. SLS, a 
powder-based additive manufacturing (AM) process, 
is capable of fabricating bioactive porous structures 
with very complex architecture, thus permitting great-
er design freedom. This process has been applied to 
form both porous natural grade PEEK and porous 
bioactive PEEK components. Use of SLS technique 
has been hampered by difficulty in loading the 
quantity of bioactive filler beyond 22% by volume 
(v/v), and exceeding porosity beyond 70%–74% 
(v/v)[13]. Compression moulding is perhaps the most 
appropriate form of material processing to produce 
bioactive PEEK compounds due to its ability to 
incorporate both porosity and bioactivity into PEEK 
with fewer limitations in terms of cost, pore 
interconnectivity, and level of bioactive filler loading 
in comparison to other techniques.   
Current methods of bioactive PEEK processing, as 
discussed earlier, do not permit control on distribution 
of bioactive phase within the PEEK matrix. These 
techniques rely on simple mixing of PEEK with bio-
active material powders/granules, and thus less control 
on distribution. In addition, the wide range of physical 
properties of different particles (size, shape, density) 
negates efficient and consistent mixing. The purpose 
of this study is to develop a novel technique that 
would permit greater control on incorporation of bio-
active materials into PEEK than the existing tech-
niques.  
2. Materials and Methods 
Figure 1 depicts workflow of the technique applied to 
make bioactive PEEK/HA composite. It comprises of 
fabrication of porous bioactive HA scaffold using ex-
trusion-based AM technology, followed by PEEK melt 
infiltration into HA scaffolds through compression 
moulding process. To produce a fully interconnected 
porous PEEK, the produced PEEK/HA composite was 
further soaked into hydrochloric acid (HCl) solution 
so that the HA network could be removed by HCl 
etching. Solvent-based extrusion freeforming process, 
first developed by Evans and Yang’s research 
group[15–25], was used to print highly uniform HA 3D 
lattice structures with controlled filament/pore size. In 
solvent-based extrusion freeforming, solidification is 
based on solvent evaporation which has advantages 
over similar techniques such as robocasting, where the 
state changes based on a dilatant transition.  
The process of solvent-based extrusion freeforming 
of the HA scaffolds involved the following steps: (i) 
preparation of HA paste, (ii) 3D printing, and (iii) 
drying, debinding and sintering of the 3D printed 
scaffold. An extrusion-based 3D printer was designed 
and built in-house for 3D printing of porous HA scaf-
folds from HA paste.  
The following materials were used to form the HA 
paste: (i) hydroxyapatite powder (HA, Ca10(PO4)6 
(OH)2, Grade P221 S, Plasma Biotal Ltd. UK) with 
density of 3156 kg·m–3 and particle size within the 
range of 1–5 µm (Figure 2(A)); (ii) polyvinyl butyral 
(PVB, Grade BN18, Whacker Chemicals, UK) with 
density of 1100 kg·m–3; (iii) polyethylene glycol (PEG, 
MW = 600, Whacker Chemicals, UK) with density of 
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Figure 1. The workflow of the technique to integrate solvent-based extrusion freeforming and compression moulding for production 
of PEEK/HA composite. 
1127 kg·m–3; (iv) propan-2-ol (Fisher Scientific, UK) 
with density of 789 kg·m–3. For production of HA 
paste, adhesive binder polyvinylbutyral (PVB), and 
plasticizer polyethyleneglycol (PEG) were fully 
dissolved in propan-2-ol solvent, with the ratio of 75% 
(w/v) PVB and 25% (w/v) PEG. HA powder was then 
added (60% (v/v) of HA based on the dried paste) to 
the solution, and stirred for 2 hours to achieve a 
well-dispersed solution. Following this, excess solvent 
was evaporated by fast stirring, and blowing hot air 
until a viscous HA paste was achieved. HA paste was 
then loaded into a homemade stainless steel syringe 
for 3D printing. Following the printing process, it is 
necessary to dry the scaffolds. Standard practice to 
achieve this is to leave the scaffold at room tempera-
ture for 24 hours to allow evaporation of excess sol-
vent, and subsequently to place the scaffold in an oven 
for debinding and sintering. The sintering protocol of 
HA was developed from Evans and Yang’ previous 
studies[22] in which the maximum sintering tempera-
ture was 1300℃ with a dwelling time of two hours. 
The sintered HA scaffolds were overmoulded with 
PEEK OPTIMA®LT3 UF (Invibio Biomaterials 
Solutions, UK, used as received) through a 
compression moulding process using both static and 
dynamic loads to produce a PEEK/HA composite. 
PEEK OPTIMA®LT3 UF has a median particle size 
of 10 µm, (Figure 2(B)) and an average molecular 
weight of 83000 Da, which is an easy flow grade 
PEEK, with a melt index of 36.4 under conditions of 
2.16 kg load in 10 min. The optimal temperature of 
400℃ was determined through experimentation on 
overmoulding HA scaffolds with external dimensions 
of 10 × 10 × 3 mm, 250 µm filaments, and 200 µm 
pore sizes, with an optimal pressure of approximately 
0.39 MPa. A mould with an internal diameter of 25 
mm was prepared from tool steel, with appropriate 
ventilation on the inferior surface to avoid trapping air 
within the composite. Both static and dynamic loading 
methods were performed as follows: 
• Static Loading: mould was heated up to 250℃, 
then load applied, and pressure maintained until the 
temperature reached 400℃. Temperature and load 
were maintained for a further 20 minutes (dwelling 
time), then heating was stopped, and the mould was 
left to cool under pressure, whereby the PEEK matrix 
crystallized and solidified. Composites were removed  
from the mould when the temperature had fallen to 
just below the glass transition temperature (143℃), 
 
 
Figure 2. (A) Scanning electron micrograph of the used HA, (B) 
PEEK powder. 
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followed by cooling to room temperature, thus miti-
gating thermal stress and cracking. 
• Dynamic Loading: Mould was heated up to 400℃ 
and maintained for 20 minutes. Load was applied for 
5 seconds before heating was stopped, then the mould 
was left to cool under pressure, until the temperature 
fell below 143℃, at which the sample was removed.   
A series of HA scaffolds with a range of filament 
and pore sizes were 3D printed, and subsequently 
overmoulded using dynamic loading to investigate the 
effects of filament/pore size on PEEK infiltration 
depth into the HA scaffold. The effect of dwelling 
time at the target temperature on the formation of 
PEEK HA composites was also explored. Through 
experimentation of the effect of load application dur-
ing load and dwelling time, it was possible to optimize 
infiltration of molten PEEK through the HA pores 
without causing degradation of the polymer. Table 1 
shows the details of the samples and the condition of 
the experiments. Samples were cut using diamond 
cutter (Mecatome T210, Presi, France). Infiltration 
depth was measured with the use of the optical micro-
scopy (Olympus BH2-UMA, Japan). Scan-
ning electron microscope (SEM) (JEOL JSM-6500F, 
Oxford Instruments, UK) was used for analysis of the 
samples. Static loading was also used to produce 
another set of PEEK/HA composites with a range of 
HA scaffold filament and pore sizes as shown in Table 
2. Computed tomography (CT) (Custom 225 kV 
Nikon/Metris HMX ST) with a resolution of 9 µm per 
pixel (or 9 × 9 × 9 µm voxel) was performed to (i) 
determine HA percentage volume in the composite; (ii) 
investigate fractures in the HA network; and (iii) 
evaluate presence of air bubbles within the 
biocomposites after moulding. CT scanning of the 
composites was performed with a 225 kV X-ray 
source and Tungsten target and peak voltage was set 
to 120 kV with no pre-filtration. In order to achieve 
sufficient flux, 93 µA current was used (11.16 W). 
Throughout the 360 degrees rotation, 3142 projections 
were taken, with an average of 8 frames per projection 
to improve the signal to noise ratio. Exposure time of 
each projection was 177 ms with a gain of 30 dB. To 
reduce the effect of ring artefacts, shuttling was 
applied with a maximum displacement of 15 pixels. 
Projection data was reconstructed using Nikon’s 
CTPro and CTAgent reconstruction software, which 
uses a filtered back projection algorithm. VG Studio 
Max 2.1 image processing application was used to 
standardize the volume (average volume of 220.14 
mm3) analysed from each sample. 
3. Results  
HA scaffolds with a range of filament and pore sizes 
were printed using the bespoke developed 3D printer. 
Through control of the printing parameters such as 
solvent content, paste deposition speed, and layer 
thickness, the microstructure of the scaffolds could be 
determined. HA filaments were delivered with high 
precision, with diameters down to 50 µm, achieved 
with the use of customized nozzle with a small die 
land length. The printed scaffolds were highly uniform, 
with a consistent and repeatable production process. 
Figures 3(A) and 3(B) depict SEM images of a sin-
tered 3D printed HA scaffold, and a magnified    
image of a fractured region (the red rectangle), 
 
Table 1. Specifications of the samples overmoulded under different conditions 
HA scaffold size Designed scaffold filament/pore size (µm) 
Moulding 
pressure (MPa) 
Loading  
type 
Dwelling time 
(min) 
Moulding temper-
ature (℃) 
Heating rate 
(℃/min) 
10×10×3 mm 250/200 0.39 static 20 400 20 
10×10×3 mm 400/400 0.39 dynamic 20 400 20 
10×10×3 mm 400/500 0.39 dynamic 4, 12, 16, 20 400 20 
10×10×3 mm 400/550 0.39 dynamic 20 400 20 
10×10×3 mm 400/670 0.39 dynamic 20 400 20 
20×18×3.7 mm 910/1200 0.39 dynamic 20 400 20 
 
Table 2. Details of the PEEK/HA samples prepared for CT analysis; pressure 0.39 MPa, static loading, moulding temperature 400℃, 
dwelling time: 20 min, heating rate 20℃/min 
Designed scaffold  
filament/pore size (µm) 250/200 250/400 400/250 400/400 400/550 400/700 
Qt. 2 2 1 1 1 5 
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respectively. As seen in Figure 3(B), pores within the 
range of 1–5 µm in both fractured surface and external 
surfaces of the filament were realized through sinter-
ing. The rough surface of HA filaments has the poten-
tial to promote osteointegration in vivo. The main 
advantage of solvent-based extrusion freeforming is 
that both macroporosity of scaffold or spacing (yellow 
areas in Figure 3(A)) and microporosity of filaments 
(in Figure 3(B)) are controllable. Macroporosity was 
controlled via computer design, and microporosity via 
alternation in sintering temperature and dwelling time. 
 
 
Figure 3. (A) A typical sintered HA scaffold with uniform mi-
crostructure and macroporosity (yellow rectangles), (B) a mag-
nified image of the selected region (red rectangle) which in-
cludes both external and internal surface of filaments. 
Like most conventional polymers, the viscosity of 
PEEK decreases with increasing temperature. The 
melting temperature of PEEK is approximately 340℃, 
and at temperatures of 360℃ to 400℃, the shear vis-
cosity of PEEK varies from ~77×103 Pa∙s to ~66×103 
Pa∙s. Therefore, to enable minimum shear viscosity, a 
mould temperature of 400℃ was used. Conrad et 
al.[26] demonstrated that this increased mould temper-
ature may also increase the compressive modulus, 
yield strength and strain of the traditional PEEK/HA 
composites. Working temperatures greater than 380℃ 
have been shown to reduce crystallinity, which is 
known to be beneficial for ductility and 
toughness[27,28], with no adverse effect on 
biocompatibility in vivo[27]. Given the positive effects 
described on both shear viscosity and mechanical 
properties of the resulting PEEK samples, a mould 
temperature of 400℃ was selected for this study. 
While mould temperatures of 400℃  guarantee 
minimum viscosity, caution must be exercised when 
working at temperatures in excess of 380℃ as there is 
a risk of thermal oxidation[26]. Potential of oxidation 
can be decreased by a reduction in dwelling time at 
the target temperature; as such optimisation of dwel-
ling time is crucial. An insufficient dwelling time will 
result in inadequate melting of PEEK and therefore, 
failure to perfuse the scaffold pores at low pressure. 
Dwelling time must be sufficient to permit adequate 
heat transfer throughout the powder, including powder 
residing at a distance from the heat source. Conversely, 
prolonged time at the target temperature will result in 
thermal oxidation and degradation of the polymer. 
Samples with 400 µm filament and 500 µm pore sizes 
were overmoulded using dwelling times of 4, 12, 16, 
and 20 minutes, under dynamic loading (details in 
Table 1). Four minutes dwelling time was insufficient 
to melt the PEEK, 12 minutes resulted only in partial 
melting (Figure 4(A)), and 16 minutes dwelling time 
resulted in complete melting of the PEEK, but 
inadequate scaffold infiltration (Figure 4(B)). It was 
determined that 20 minutes was the optimal dwelling 
time for compression moulding of PEEK at 400℃, 
permitting adequate melt flowability to fill the lattice 
structures with no apparent polymer degradation. 
PEEK degradation was realized by visual observation 
(i.e., colour change in PEEK) in this study. 
 
 
Figure 4. Bioactive PEEK/HA composites, scaffolds size 10 × 
10 × 3 mm, filament size: 400 µm, pore size 500 µm, moulding 
temperature: 400ºC, pressure: 0.39 MPa, dynamic loading for 5 
s; (A) dwelling time: 12 min, heating rate: 20℃/min, and (B) 
dwelling time: 16 min, heating rate: 20℃/min. 
3D printed HA scaffolds are relatively fragile and 
moulding pressure must be carefully regulated to per-
mit  flow of molten PEEK and perfusion of fine 
pores without resulting in fracturing of the HA net-
work. The results of our previous mechanical tests on 
extrusion freeformed HA scaffolds indicated that 
compressive loading must be less than 1 MPa[29], 
which is remarkably less than what has been reported 
for moulding of PEEK/HA powders. Roeder’s group 
densified PEEK and HA-whisker dry powders at 125 
MPa first, to avoid porosity, and then compression 
moulded at 250 MPa and 350℃–370℃[8]. Wong et 
al.[5] described an alternative technique in which 
PEEK and strontium-containing HA (Sr-HA) powders 
were densified at 35 MPa and then compression 
b
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moulded at 12–15 MPa and 350℃–375℃. The use of 
injection pressures of 11–14 MPa and temperature of 
395℃was previously used in the injection moulding 
of PEEK/HA compounds[4]. Through experimentation, 
the optimal pressure to ensure full infiltration of a 
scaffold at size 10 × 10 × 3 mm without resulting in 
damage, was determined to be in the region of 0.39 
MPa. The optimal pressure used in this study is simi-
lar to that used by other researchers in the compres-
sion moulding of reinforced carbon fibre-PEEK com-
posites[30–32]. Luo et al.[30] tested pressures ranging 
from 0.5 to 2.0 MPa and found that 0.5 MPa is the 
most suitable pressure for making 3D carbon-fibre 
reinforced PEEK (CFR-PEEK) composites prepared 
by 3D co-braiding and compression moulding tech-
niques. Mrse and Piggott[32] employed 0.4 MPa pres-
sure for the preparation of AS-4 CFR-PEEK using 
lay-up followed by compression moulding process to 
avoid fibre damage. CT analysis was used to visualize 
the PEEK/HA composite and to detect over-
load-induced defects in HA network following com-
pression moulding. Defects manifested in the form of 
either a partial crush, or micro-cracks (red arrows) in 
the HA filaments (Figure 5). 
While the mechanical and biological functions of 
the composites can be tailored by varying the filament 
and pore size of the scaffold, there are lower limits for 
these parameters. Small filaments can fracture during 
compression moulding and molten PEEK is too visc-
ous to infiltrate small pores. It was found that for 
scaffolds of 10 × 10 × 3 mm exposed to a moulding 
pressure of 0.39 MPa, the filament size and the spacing 
are required to be greater than 250 μm and 200 μm  
respectively to ensure successful PEEK infiltration 
without HA fracture. Dynamic compression was ap-
plied on PEEK/HA composites produced using scaf- 
 
 
Figure 5. CT images of two typical damaged HA scaffolds 
after PEEK infiltration using excessive pressure; (A) partially 
crushed scaffold where filament is 250 µm and pore is 250 µm, 
(B) HA scaffold with micro-cracked filaments where filament 
is 400 µm and pore is 550 µm. 
folds with a range of filament and pore sizes through 
conditions presented in Table 1. Infiltration depth was 
shown to be proportional to the pore size so that the 
scaffold, with dimensions of 20 × 18 × 3.7 mm, and 
filaments sized 910 μm while pores are 1200 μm, was 
found to be fully infiltrated by PEEK in both lateral 
and vertical directions, and HA network retained its 
structure and shape. For similar sized scaffolds that 
are 400 µm in filament size but of differing pore sizes 
(400, 500, 550 and 670 µm), the respective infiltration 
depths are as follows: 1.4, 1.9, 2.4 and 2.9 mm. When 
the infiltration depths—using dynamic loading—are 
compared with the infiltration as seen following static 
loading, it can be concluded even in scaffolds with 
pores of 200 μm that dynamic loading of the molten 
PEEK does not permit sufficient time for flow through 
the scaffold. Infiltration depth was found to be more 
dependent on the temporal application of pressure 
than the absolute magnitude of the pressure. Thus, 
different pore sizes ranging from 200 µm to 700 µm 
can be fully infiltrated easily using static loading 
without filament fracture. Furthermore, dynamic 
loading was found to result in greater entrapment of 
air in the PEEK/HA matrix than static loading. This 
implies that during dynamic loading, air is unable to 
escape from the PEEK matrix with a resulting de-
crease in mechanical strength. 
A static pressure of 0.39 MPa, dwelling time of 20 
min and temperature of 400℃were found to be op-
timal for compression moulding of HA scaffolds of 10 
× 10 × 3 mm in size with filament size above 250 µm 
and pore size above 200 µm. CT analysis of PEEK/ 
HA composites where proportion of HA ranges from 
approximately 35% (v/v) to 77% (v/v) and are pre-
pared by static loading, resulted in an average of 1.5% 
(v/v) air within the composite. CT scanning of the 
samples where scaffolds had larger pore size (i.e. less 
HA content) of 700 µm revealed that increasing pore 
size in the scaffolds can result in formation of more air 
bubble (up to approximately 7% (v/v)) within PEEK 
matrix. Figure 6 shows representative 3D images ob-
tained using CT, imaging various cross sections of a 
typical PEEK/HA composite. The majority of air bub-
bles (which can be realized in dark color) are located 
superiorly in the images, which corresponds to the 
inferior surface of the mould where air release would 
be most likely to be impeded. The sintering-induced 
microporosity in HA filaments can be realized (the red 
arrow) in the magnified view in Figure 6(E).  
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Figure 6. 3D image constructed from CT scan of a PEEK/HA composite with HA filament sized 400 μm and pore size of 700 μm; (A) 
isometric view (total volume 200.14 mm3), (B) vertical section view, (C) horizontal section view, (D) oblique section view, (e) mag-
nified view of HA filament within PEEK matrix, (F) front view of the PEEK/HA composite with broken/dislocated HA filaments. 
Figures 7(A) and (B) depict SEM images of ver-
tical sections from typical PEEK/HA composite 
produced successfully through compression mould-
ing using static loading and PEEK-HA interface as 
seen in Figure 7(C)(the magnified view). Figure 7(D) 
shows a hole produced by soaking the PEEK/HA 
composite into HCl solution for 72 hours. HA fila-
ments were dissolved in HCl, resulting in hollow 
channels suitable for cell attachment, infiltration and 
proliferation. As seen in Figures 7(A) and (B), HA 
scaffolds are fully infiltrated by PEEK in both ver-
tical (infiltration depth was 3 mm) and lateral direc-
tions, while maintaining the HA network structure 
and uniformity. Whilst a good interface between HA 
filaments and PEEK matrix is realized (Figure 7(C)), 
this may not affect the mechanical properties of the 
composite. In CFR-PEEK, good bonding between 
PEEK matrix and carbon fibers is critical and deter-
mines the overall strength of the composite as it 
enables load transfer from PEEK to carbon fibers. 
However, in these PEEK/HA composites, the inter-
face bonding might not be as important in CFR- 
PEEK since brittle HA filaments are used for its bio-
activity, rather than its load-bearing properties. In 
contrast, HA scaffold volume fraction and filament 
diameter/layer orientation could be pivotal in deter-
mining the mechanical properties of the final com-
posite, which is what we plan to investigate in the 
future. The interface achieved between HA filaments 
and PEEK matrix as shown in Figure 7(C) proves 
that the moulding temperature and pressure were 
appropriate selections.  
 
 
Figure 7. (A) and (B) Bioactive PEEK/HA composite: scaffold 
size 10 × 10 × 3 mm; HA scaffold filament size: 250 µm; 
moulding temperature: 400℃, dwelling time: 20 min, heating 
rate: 20℃/min, static pressure: 0.39 MPa; (C) close view of 
HA/PEEK interface; (D) a hole produced in PEEK by soaking 
PEEK/HA composite into HCl solution for 72 hours. 
 
4. Discussion and Conclusion 
Various manufacturing processes including the tradi-
tional chemical engineering methods and advanced 
AM techniques can be used for the construction of 
biomaterial scaffolds. Traditional techniques such as 
solvent casting/salt leaching, phase separation, foam-
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ing, etc. have several limitations such as shape restric-
tions, manual intervention, inconsistency, and inflex-
ibility. The use of solvent-based extrusion freeforming 
in this project guaranteed reproducibility and unifor-
mity of the 3D printed HA scaffolds. Moreover, the 
technique can deliver much finer filaments (down to 
50 μm) and avoid the thermal management issues of 
other extrusion-based techniques. The versatility of 
the method is not just in terms of structure and fila-
ment dimensions,  but also in terms of the capability 
to utilize a range of ceramic powders (such as zirconia, 
alumina, HA, TCP, Bioglass, etc.) according to the 
desired properties. The key feature of our in-house 
developed solvent-based extrusion freeforming me-
thod is its unique nozzle design with minimum die 
land, and paste formulation, which allows us to make 
very uniform pastes quickly with an excellent extru-
dability and less nozzle jamming during extrusion. 
The additive nature of the process ensures minimal 
waste of biomaterial and renders it suitable for mass 
production of porous bioactive structures[33], and mi-
cro-scale woodpile structures[34] for use as scaffolds. 
The printed HA scaffolds were highly uniform which 
makes the overall process very consistent and repeata-
ble for further use in compression moulding process. 
A number of researchers have reported the use of 
polymer infiltration into bioceramic scaffolds to in-
crease mechanical properties[35–40]. In these studies, 
bioceramic porous structures were immersed in mol-
ten polymer or solution to achieve infiltration of either 
the filaments or the entire structure. Martínez-Vázquez 
et al.[35] immersed extrusion freeformed β-TCP scaf-
folds into molten polylactic acid (PLA) and polyca-
prolactone (PCL) for 2 hours to produce composite 
bioceramic/polymer composite. These techniques 
were not suitable for use in this study as viscosity of 
easy flow medical grade PEEK is still much greater 
than PCL or PLA. This renders the process of infiltra-
tion of fine pores by immersion unreliable, resulting in 
scaffold material being retained on the surface of 
viscous PEEK melt. In addition, medical grade PEEK 
tends to degrade when it is held in excess of 30 mi-
nutes at temperatures above 400℃ in the absence of a 
vacuum. Ma et al.[41] used compression moulding to 
make a simple functionally graded PEEK/HA compo-
sites. Roeder’s group at University of Notre Dame, 
USA, reported successful use of compression mould-
ing and particulate leaching to make porous bioactive 
PEEK/HA-whisker composite[5–8]. Bioactive particles 
and/or a fugitive particle are mixed with PEEK powd-
ers, and then the mixture is densified by pressure, and 
finally, compression moulded. A similar compression 
moulding process was used in this study for infiltra-
tion of 3D printed HA lattice structures, barring the 
fact that there is no requirement for mixing and densi-
fication of PEEK and HA powders. 
The proposed technique provides new possibilities 
for producing both bioactive PEEK compounds and 
porous PEEK structures with theoretically enhanced 
biological performance. In addition, both bioactive 
phase and PEEK matrix are fully interconnected, 
which is a superior advantage compared to existing 
techniques. Whilst HA, a well-known osteoconductive 
material was used in this work, other bioactive mate-
rials such as Bioglass, β-TCP, etc. with higher biode-
gradation rates can be used. The interconnected bioac-
tive network can be fully absorbed in vivo, leaving 3D 
interconnected channels for further in-growth and pro-
liferation. In this way, a 3D locked bone/PEEK struc-
ture could be achieved in vivo which can remarkably 
improve graft fixation compared with existing tech-
niques.  
In addition to PEEK/HA composite, the proposed 
technique could be utilized to produce PEEK with 
fully interconnected pores and controlled porosity. 
Conventional techniques such as particulate leaching 
exert poor control on porosity, and suffer from limita-
tions such as inconsistency and require manual inter-
vention. Using the proposed technique, porous PEEK 
could be easily produced with much greater control on 
porosity and enhanced reproducibility, a key require-
ment in production of medical devices. Furthermore, 
this technique is a low-cost process in comparison to 
SLS, while affording greater control of pore size (the 
minimum achievable in SLS is currently 400–500 μm). 
Therefore, while SLS as an AM technology has great-
er control on pore size and architecture of biocon-
structs[42,43], its use in clinical applications is currently 
limited to those in which small pore sizes are not re-
quired. In contrast, with the use of the proposed tech-
nique, a wide range of pore sizes (200–1000 µm) is 
achievable. This makes the technique a versatile ap-
proach, enabling formation of porous PEEK which 
can be tailored to specific biomechanical requirements 
of a variety of clinical applications. 
To summarize, the main features of these new 
PEEK/HA composite are: 
• Greater control on distribution of bioactive phase 
within PEEK matrix (controlled by computer design), 
• Ability to tailor mechanical and biological proper-
A novel bioactive PEEK/HA composite with controlled 3D interconnected HA network 
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ties by varying percentage of bioactive phase (by ei-
ther varying HA filament or pore size), 
• Various bioactive materials such as Bioglass, β- 
TCP, etc. with faster biodegradation rate than HA can 
be served so that the bioactive network leaves 3D in-
terconnected channels after absorbing in vivo for fur-
ther bone cells in-growth and proliferation, 
• 100% interconnectivity of both bioactive network 
and PEEK brings about maximum structural integrity 
of the composite, 
• Ability to incorporate bioactive materials with a 
very high volumetric percentage (in this study up to 
77% (v/v) HA) for non-load bearing applications such 
as craniomaxillofacial plates, etc. 
Quality control standards stipulate that testing of 
medical device biocompatibility requires extensive 
investigation in order to confirm the true readiness for 
clinical application. As a precursor to future develop-
ments, our objective for this study was to show the 
preliminary evidences supporting feasibility of com-
pression moulding of very fragile HA scaffolds with 
PEEK. Further studies have been planned to include 
mechanical properties assessment, and in vitro cell 
differentiation, proliferation and molecular assays. 
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